OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques

Psychoneuroendocrinology

Volumn 36, Issue 9, 2011, Pages 1303-1311

  Schwandt, Melanie L ^a   Lindell, Stephen G ^a   Higley, James D ^b   Suomi, Stephen J ^c   Heilig, Markus ^a   Barr, Christina S ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Alcohol; Cortisol; Hypothalamic pituitary adrenal (HPA) axis; Nonhuman primate; Opioids; Postpartum depression; Separation; Stress

Indexed keywords

ALCOHOL; CORTICOTROPIN; HYDROCORTISONE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; JUVENILE ANIMAL; MALE; MATERNAL DEPRIVATION; NONHUMAN; OPRM1 GENE; PRIORITY JOURNAL; PUERPERIUM; RHESUS MONKEY; STRESS;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; ANIMALS, NEWBORN; ETHANOL; FEMALE; GENETIC VARIATION; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MACACA MULATTA; MALE; MATERNAL DEPRIVATION; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPARTUM PERIOD; PREGNANCY; RECEPTORS, OPIOID, MU; STRESS, PSYCHOLOGICAL;

EID: 80052704835     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.03.002     Document Type: Article

References (88)

1. Adinoff B., Junghanns K., Kiefer F., Krishnan-Sarin S. Suppression of the HPA axis stress-response: implications for relapse. Alcoholism, Clinical and Experimental Research 2005, 29:1351-1355.
2. Anton R.F., Oroszi G., O'Malley S., Couper D., Swift R., Pettinati H., Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry 2008, 65:135-144.
3. Barr C.S., Dvoskin R.L., Gupte M., Sommer W., Sun H., Schwandt M.L., Lindell S.G., Kasckow J.W., Suomi S.J., Goldman D., Higley J.D., Heilig M. Functional CRH variation increases stress-induced alcohol consumption in primates. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14593-14598.
4. Barr C.S., Newman T.K., Lindell S., Becker M.L., Shannon C., Champoux M., Suomi S.J., Higley J.D. Early experience and sex interact to influence limbic-hypothalamic-pituitary-adrenal-axis function after acute alcohol administration in rhesus macaques (Macaca mulatta). Alcoholism, Clinical and Experimental Research 2004, 28:1114-1119.
5. Barr C.S., Newman T.K., Shannon C., Parker C., Dvoskin R.L., Becker M.L., Schwandt M., Champoux M., Lesch K.P., Goldman D., Suomi S.J., Higley J.D. Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biological Psychiatry 2004, 55:733-738.
6. Barr C.S., Schwandt M., Lindell S.G., Chen S.A., Goldman D., Suomi S.J., Higley J.D., Heilig M. Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Archives of General Psychiatry 2007, 64:369-376.
7. Barr C.S., Schwandt M.L., Lindell S.G., Higley J.D., Maestripieri D., Goldman D., Suomi S.J., Heilig M. Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:5277-5281.
8. Bayart F., Hayashi K.T., Faull K.F., Barchas J.D., Levine S. Influence of maternal proximity on behavioral and physiological responses to separation in infant rhesus monkeys (Macaca mulatta). Behavioral Neuroscience 1990, 104:98-107.
9. Befort K., Filliol D., Decaillot F.M., Gaveriaux-Ruff C., Hoehe M.R., Kieffer B.L. A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. Journal of Biological Chemistry 2001, 276:3130-3137.
10. Beyer A., Koch T., Schroder H., Schulz S., Hollt V. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. Journal of Neurochemistry 2004, 89:553-560.
11. Bodnar R.J. Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 2004, 25:697-725.
12. Bond A., O'Neill M.J., Hicks C.A., Monn J.A., Lodge D. Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport 1998, 9:1191-1193.
13. Bridges R.S., Hammer R.P. Parity-associated alterations of medial preoptic opiate receptors in female rats. Brain Research 1992, 578:269-274.
14. Chong R.Y., Oswald L., Yang X., Uhart M., Lin P.I., Wand G.S. The micro-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 2006, 31:204-211.
15. Chou W.Y., Wang C.H., Liu P.H., Liu C.C., Tseng C.C., Jawan B. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 2006, 105:334-337.
16. Chou W.Y., Yang L.C., Lu H.F., Ko J.Y., Wang C.H., Lin S.H., Lee T.H., Concejero A., Hsu C.J. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiologica Scandinavica 2006, 50:787-792.
17. Chrousos G.P., Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992, 267:1244-1252.
18. Coe C.L., Wiener S.G., Rosenberg L.T., Levine S. Endocrine and Immune Responses to Separation and Maternal Loss in Nonhuman Primates 1985, pp. 165-199.
19. Dawson D.A., Goldstein R.B., Moss H.B., Li T.K., Grant B.F. Gender differences in the relationship of internalizing and externalizing psychopathology to alcohol dependence: likelihood, expression and course. Drug and Alcohol Dependence 2010.
20. Dettling A., Pryce C.R., Martin R.D., Dobeli M. Physiological responses to parental separation and a strange situation are related to parental care received in juvenile Goeldi's monkeys (Callimico goeldii). Developmental Psychobiology 1998, 33:21-31.
21. Dettling A.C., Feldon J., Pryce C.R. Early deprivation and behavioral and physiological responses to social separation/novelty in the marmoset. Pharmacology, Biochemistry and Behavior 2002, 73:259-269.
22. Drolet G., Dumont E.C., Gosselin I., Kinkead R., Laforest S., Trottier J.F. Role of endogenous opioid system in the regulation of the stress response. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2001, 25:729-741.
23. Ebner K., Wotjak C.T., Landgraf R., Engelmann M. Neuroendocrine and behavioral response to social confrontation: residents versus intruders, active versus passive coping styles. Hormones and Behavior 2005, 47:14-21.
24. Fillingim R.B., Kaplan L., Staud R., Ness T.J., Glover T.L., Campbell C.M., Mogil J.S., Wallace M.R. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. Journal of Pain 2005, 6:159-167.
25. Frew A.K., Drummond P.D. Negative affect, pain and sex: the role of endogenous opioids. Pain 2007, 132(Suppl. 1):S77-S85.
26. Garbutt J.C., Kranzler H.R., O'Malley S.S., Gastfriend D.R., Pettinati H.M., Silverman B.L., Loewy J.W., Ehrich E.W. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 2005, 293:1617-1625. Vivitrex Study Group.
27. Garriock H.A., Tanowitz M., Kraft J.B., Dang V.C., Peters E.J., Jenkins G.D., Reinalda M.S., McGrath P.J., von Zastrow M., Slager S.L., Hamilton S.P. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. American Journal of Psychiatry 2010, 167:565-573.
28. Gianoulakis C. Endogenous opioids and addiction to alcohol and other drugs of abuse. Current Topics in Medicinal Chemistry 2004, 4:39-50.
29. Gianoulakis C. Endogenous opioids and addiction to alcohol and other drugs of abuse. Current Topics in Medicinal Chemistry 2009, 9:999-1015.
30. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Molecular Psychiatry 2002, 7:254-275.
31. Groer M.W., Morgan K. Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology 2007, 32:133-139.
32. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
33. Hernandez-Avila C.A., Wand G., Luo X., Gelernter J., Kranzler H.R. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). American Journal of Medical Genetics B: Neuropsychiatric Genetics 2003, 118:60-65.
34. Higley J.D., Suomi S.J., Linnoila M. A longitudinal assessment of CSF monoamine metabolite and plasma cortisol concentrations in young rhesus monkeys. Biological Psychiatry 1992, 32:127-145.
35. Janicki P.K., Schuler G., Francis D., Bohr A., Gordin V., Jarzembowski T., Ruiz-Velasco V., Mets B. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesthesia and Analgesia 2006, 103:1011-1017.
36. Jolley S.N., Betrus P. Comparing postpartum depression and major depressive disorder: issues in assessment. Issues in Mental Health Nursing 2007, 28:765-780.
37. Jolley S.N., Elmore S., Barnard K.E., Carr D.B. Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression. Biological Research for Nursing 2007, 8:210-222.
38. Kalin N.H., Shelton S.E., Barksdale C.M. Opiate modulation of separation-induced distress in non-human primates. Brain Research 1988, 440:285-292.
39. Kennedy S.E., Koeppe R.A., Young E.A., Zubieta J.K. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Archives of General Psychiatry 2006, 63:1199-1208.
40. Kim S.G., Kim C.M., Choi S.W., Jae Y.M., Lee H.G., Son B.K., Kim J.G., Choi Y.S., Kim H.O., Kim S.Y., Oslin D.W. A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients. Psychopharmacology 2009, 201:611-618.
41. Klepstad P., Rakvag T.T., Kaasa S., Holthe M., Dale O., Borchgrevink P.C., Baar C., Vikan T., Krokan H.E., Skorpen F. The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiologica Scandinavica 2004, 48:1232-1239.
42. Korte S.M., Koolhaas J.M., Wingfield J.C., McEwen B.S. The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neuroscience and Biobehavioral Reviews 2005, 29:3-38.
43. Kreek M.J. Opiates, opioids and addiction. Molecular Psychiatry 1996, 1:232-254.
44. Kroslak T. The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. Journal of Neurochemistry 2007, 103:77-87.
45. LaForge K.S., Yuferov V., Kreek M.J. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. European Journal of Pharmacology 2000, 410:249-268.
46. Laszlo F.A., Varga C., Pavo I., Gardi J., Vecsernyes M., Galfi M., Morschl E., Laszlo F., Makara G.B. Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2001, 280:R458-R465.
47. Lerman C., Wileyto E.P., Patterson F., Rukstalis M., Udrain-McGovern J., Restine S., Shields P.G., Kaufmann V., Redden D., Benowitz N., Berrettini W.H. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics Journal 2004, 4:184-192.
48. Lotsch J., Geisslinger G. Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers. Pharmacogenomics Journal 2006, 6:200-210.
49. Lymangrover J.R., Dokas L.A., Kong A., Martin R., Saffran M. Naloxone has a direct effect on the adrenal cortex. Endocrinology 1981, 109:1132-1137.
50. Mann P.E., Kinsley C.H., Ronsheim P.M., Bridges R.S. Long-term effects of parity on opioid and nonopioid behavioral and endocrine responses. Pharmacology, Biochemistry and Behavior 1989, 34:83-88.
51. Martin P., Kraemer H.C. Individual differences in behavior and their statistical consequences. Animal Behaviour 1987, 35:1366-1375.
52. Mastorakos G., Ilias I. Maternal hypothalamic-pituitary-adrenal axis in pregnancy and the postpartum period. Postpartum-related disorders. Annals of the New York Academy of Sciences 2000, 900:95-106.
53. Mastorakos G., Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Annals of the New York Academy of Sciences 2003, 997:136-149.
54. McNally A.M., Palfai T.P., Levine R.V., Moore B.M. Attachment dimensions and drinking-related problems among young adults-the mediational role of coping motives. Addictive Behaviors 2003, 28:1115-1127.
55. Miller G.M., Bendor J., Tiefenbacher S., Yang H., Novak M.A., Madras B.K. A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression. Molecular Psychiatry 2004, 9:99-108.
56. Mineka S., Suomi S.J. Social separation in monkeys. Psychological Bulletin 1978, 85:1376-1400.
57. Morrow A.L., Porcu P., Boyd K.N., Grant K.A. Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior. Dialogues in Clinical Neuroscience 2006, 8:463-477.
58. Nelson E.E., Panksepp J. Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepinephrine. Neuroscience and Biobehavioral Reviews 1998, 22:437-452.
59. O'Malley S.S., Krishnan-Sarin S., Farren C., Sinha R., Kreek M.J. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl.) 2002, 160:19-29.
60. Oertel B.G., Schmidt R., Schneider A., Geisslinger G., Lotsch J. The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenetics and Genomics 2006, 16:625-636.
61. Olff M. Stress, depression and immunity: the role of defense and coping styles. Psychiatry Research 1999, 85:7-15.
62. Olff M., Langeland W., Gersons B.P. Effects of appraisal and coping on the neuroendocrine response to extreme stress. Neuroscience and Biobehavioral Reviews 2005, 29:457-467.
63. Oslin D.W., Berrettini W., Kranzler H.R., Pettinati H., Gelernter J., Volpicelli J.R., O'Brien C.P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003, 28:1546-1552.
64. Panksepp J., Nelson E., Siviy S. Brain opioids and mother-infant social motivation. Acta Paediatrica Supplement 1994, 397:40-46.
65. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences 2008, 31:464-468.
66. Piazza P.V., Le M.M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Research - Brain Research Reviews 1997, 25(3):359-372.
67. Pratt W.M., Davidson D. Role of the HPA axis and the A118G polymorphism of the mu-opioid receptor in stress-induced drinking behavior. Alcohol and Alcoholism 2009, 44:358-365.
68. Ray L.A., Hutchison K.E. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcoholism, Clinical and Experimental Research 2004, 28:1789-1795.
69. Ray R., Jepson C., Patterson F., Strasser A., Rukstalis M., Perkins K., Lynch K.G., O'Malley S., Berrettini W.H., Lerman C. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology 2006, 188:355-363.
70. Ribeiro S.C., Kennedy S.E., Smith Y.R., Stohler C.S., Zubieta J.K. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005, 29:1264-1280.
71. Richardson H.N., Lee S.Y., O'Dell L.E., Koob G.F., Rivier C.L. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. European Journal of Neuroscience 2008, 28:1641-1653.
72. Romberg R.R., Olofsen E., Bijl H., Taschner P.E., Teppema L.J., Sarton E.Y., van Kleef J.W., Dahan A. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology 2005, 102:522-530.
73. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry 2000, 57:925-935.
74. Schuckit M.A. Differences in plasma cortisol after ingestion of ethanol in relatives of alcoholics and controls: preliminary results. Journal of Clinical Psychiatry 1984, 45:374-376.
75. Schuckit M.A., Gold E., Risch C. Plasma cortisol levels following ethanol in sons of alcoholics and controls. Archives of General Psychiatry 1987, 44:942-945.
76. Schuckit M.A., Smith T.L., Kalmijn J. The search for genes contributing to the low level of response to alcohol: patterns of findings across studies. Alcoholism: Clinical & Experimental Research 2004, 28(10):1449-1458.
77. Sher L., Stanley B.H. The role of endogenous opioids in the pathophysiology of self-injurious and suicidal behavior. Archives of Suicide Research 2008, 12:299-308.
78. Sia A.T., Lim Y., Lim E.C., Goh R.W., Law H.Y., Landau R., Teo Y.Y., Tan E.C. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 2008, 109:520-526.
79. Slattery D.A., Neumann I.D. No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. Journal of Physiology 2008, 586:377-385.
80. Stefano G.B., Kream R. Endogenous opiates, opioids, and immune function: evolutionary brokerage of defensive behaviors. Seminars in Cancer Biology 2008, 18:190-198.
81. Teodorov E., Bernardi M.M., Ferrari M.F., Fior-Chadi D.R., Felicio L.F. Plasticity of opioid receptors in the female periaqueductal gray: multiparity-induced increase in the activity of genes encoding for Mu and kappa receptors and a post-translational decrease in delta receptor expression. Journal of Molecular Neuroscience 2010.
82. Van Ree J.M., Niesink R.J., Van W.L., Ramsey N.F., Kornet M.M., Van Furth W.R., Vanderschuren L.J., Gerrits M.A., Van den Berg C.L. Endogenous opioids and reward. European Journal of Pharmacology 2000, 405:89-101.
83. Veenema A.H., Meijer O.C., De Kloet E.R., Koolhaas J.M., Bohus B.G. Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression. Hormones and Behavior 2003, 43:197-204.
84. Volavka J., Cho D., Mallya A., Bauman J. Naloxone increases ACTH and cortisol levels in man. New England Journal of Medicine 1979, 300:1056-1057.
85. Vungkhanching M., Sher K.J., Jackson K.A., Parra G.R. Relation of attachment style to family history of alcoholism and alcohol use disorders in early adulthood. Drug and Alcohol Dependence 2004, 75:47-53.
86. Wand G.S., Mangold D., El Deiry S., McCaul M.E., Hoover D. Family history of alcoholism and hypothalamic opioidergic activity. Archives of General Psychiatry 1998, 55:1114-1119.
87. Wand G.S., McCaul M., Yang X., Reynolds J., Gotjen D., Lee S., Ali A. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002, 26:106-114.
88. Wiener S.G., Bayart F., Faull K.F., Levine S. Behavioral and physiological responses to maternal separation in squirrel monkeys (Saimiri sciureus). Behavioral Neuroscience 1990, 104:108-115.